Cargando…
Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19
Investigational treatments/drugs for coronavirus disease 2019 (COVID-19) have been applied, with repurposed or newly developed drugs, and their effectiveness has been evaluated. Some of these drugs may be hepatotoxic, and each monotherapy or combination therapy may increase the risk of drug-induced...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717018/ https://www.ncbi.nlm.nih.gov/pubmed/35068875 http://dx.doi.org/10.3748/wjg.v27.i48.8370 |